EP1704877A1 — A wound care device comprising a nitric oxide eluting polymer
Assigned to Nolabs AB · Expires 2006-09-27 · 20y expired
What this patent protects
A device, and a manufacturing process of said device, is provided that allows for treatment of wounds. The device comprises a nitric oxide (NO) eluting polymer arranged to contact the wound area to be treated, such that a therapeutic dose of nitric oxide is eluted from said nitri…
USPTO Abstract
A device, and a manufacturing process of said device, is provided that allows for treatment of wounds. The device comprises a nitric oxide (NO) eluting polymer arranged to contact the wound area to be treated, such that a therapeutic dose of nitric oxide is eluted from said nitric oxide eluting polymer to said wound area, thus promoting healing of a wound at said wound area.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.